SCHEMBL263522

SCHEMBL263522

O=CC1=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197588 0.83
SCHEMBL17653495 0.81 HDAC4 (0.34)
SCHEMBL11952530 0.81 HDAC4 (0.34)
SCHEMBL4578689 0.81 HDAC4 (0.34)
SCHEMBL11052535 0.81
SCHEMBL19743485 0.81 TRPA1 (0.33)
SCHEMBL19743486 0.81 TRPA1 (0.33)
SCHEMBL17653494 0.81 HDAC4 (0.34)
SCHEMBL20542554 0.81 HDAC4 (0.34)
SCHEMBL8521408 0.81 TRPA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107540712-A A kind of modified phosphazene compound, Preparation method and use 广东广山新材料股份有限公司 2018-01-05 CN claimed
CN-107540713-A Low dielectric phosphazene compound, the Preparation method and use of a kind of modification 广东广山新材料股份有限公司 2018-01-05 CN claimed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
CN-117736207-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-03-22 CN disclosed
CN-115362003-B Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-03-22 CN disclosed
US-11753385-B2 Method for producing kakeromycin and derivatives thereof OP BIO FACTORY CO., LTD. (JP) 2023-09-12 US disclosed
CN-115160248-A Method for producing Kakeromycin and derivatives thereof 海洋规划生物工厂株式会社 2022-10-11 CN disclosed
CN-114874131-A Method for producing Kakeromycin and derivatives thereof 海洋规划生物工厂株式会社 2022-08-09 CN disclosed
CN-114835596-A Method for producing Kakeromycin and derivatives thereof 海洋规划生物工厂株式会社 2022-08-02 CN disclosed
CN-107709335-B Method for producing Kakeromycin and derivatives thereof 海洋规划生物工厂株式会社 2022-05-31 CN disclosed
US-20220024883-A1 METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF OP BIO FACTORY CO., LTD. (JP) 2022-01-27 US disclosed
WO-1996010014-A1 ALDEHYDE DERIVATIVES AS UPSTEINE PROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-04 WO disclosed
US-5436254-A Vaopressin antagonists OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1995-07-25 US disclosed
EP-0602209-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-22 EP disclosed
EP-0382185-B1 Carbostyril derivatives OTSUKA PHARMA CO LTD (JP) 1994-06-15 EP disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed
US-5225402-A Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-07-06 US disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
US-4438277-A Hydronaphthalene derivatives SANKYO COMPANY, LIMITED (JP) 1984-03-20 US disclosed
US-4361515-A Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use SANKYO COMPANY, LIMITED (JP) 1982-11-30 US disclosed